latest news releases from the newsroom
Radius Health Reports Proof of Mechanism for RAD1901 and Presentation at 4th Annual Brain Metastases Research and Emerging Therapy Conference in September
WALTHAM, Mass., Aug. 28, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases, reports that the positron emission tomography (PET) imaging from the RAD1901 maximum tolerated dose study ("MTD") has demonstrated potent selective estrogen receptor degradation ("SERD") activity. In the ongoing MTD study, we observed via 18F-fluroestradiol positron emission tomography that a well tolerated dose of RAD1901 strongly suppressed positive baseline estrogen receptor imaging sites in the first healthy volunteer in the PET imaging cohort of the study. The study will continue to test higher doses to determine the maximum tolerated doses and to extend the PET imaging correlation with the pharmacokinetic/pharmacodynamic response to RAD1901.
Civeo to Participate in Barclays CEO Energy-Power Conference
HOUSTON, Aug. 28, 2014 (GLOBE NEWSWIRE) -- Civeo Corporation (NYSE:CVEO) announced today that Bradley J. Dodson, Civeo's President and Chief Executive Officer, and Frank C. Steininger, Civeo's Senior Vice President and Chief Financial Officer, will present at the Barclays CEO Energy-Power Conference on Tuesday, September 2, 2014 at 4:25 p.m. Eastern Time. The Company's presentation can be heard via a live webcast. A copy of the slides from the Company's presentation will be posted to the Company's website prior to the webcast.
EQS Group AG
DGAP-DD: SAF-HOLLAND S.A. english
Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG
Directors' Dealings notification transmitted by DGAP â a service of EQS Group
The person with duty of notification is solely responsible for the content
of this announcement.
Details of the person subject to the disclosure requirement
Last name: Schewerda
First name: Steffen
Capital City Bank Group, Inc.
Capital City Bank Group, Inc. Announces Quarterly Dividend
TALLAHASSEE, Fla., Aug. 28, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of Capital City Bank Group, Inc. (Nasdaq:CCBG) declared a quarterly cash dividend on its common stock of $.02 per share. The dividend, which is unchanged from the prior quarter, produces an annualized rate of $.08 per common share and is payable on September 22, 2014 to shareowners of record as of September 8, 2014. The annualized dividend yield is .57% based on a closing stock price of $13.92 on August 27, 2014.